Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Colorectal Neoplasms 2Neoplasm Metastasis 1Colorectal Cancer Metastatic 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Maraviroc × Gastrointestinal × Clear all
NCT04721301 2023-10-17

Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial

University Hospital Heidelberg

Phase 1 Completed
50 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03274804 2022-06-07

PICCASSO

University Hospital Heidelberg

Phase 1 Completed
20 enrolled 12 charts
Gastrointestinal

Colorectal Neoplasms

NCT01736813 2017-03-22

MARACON

National Center for Tumor Diseases, Heidelberg

Completed
12 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡